Answers are grounded in this paper and cite their sources.
A pulsed electromagnetic field (PEMF) enhances the efficacy of several anticancer drugs.Doxorubicin (DOX) is an anticancer agent used to treat various malignancies, including breast cancer.This study examined whether a PEMF increases the anticancer effect of DOX on MCF-7 human breast cancer cells and elucidated the underlying mechanisms affected by PEMF stimulation in DOX-treated MCF-7 human breast cancer cells.A cotreatment with DOX and a PEMF potentiated the reduction in MCF-7 cell viability compared to the treatment with DOX alone.The PEMF elevated DOX-induced G1 arrest by affecting cyclin-dependent kinase 2 phosphorylation and the expression of G1 arrest-related molecules, including p53, p21, cyclin E2, and polo like kinase 1.In addition, PEMF increased the DOX-induced upregulation of proapoptotic proteins, such as Fas and Bcl-2-associated X, and the downregulation of antiapoptotic proteins, including myeloid leukemia 1 and survivin.PEMF promoted the DOX-induced activation of caspases-8, -9, and -7 and poly (adenosine diphosphateribose) polymerase cleavage in MCF-7 cells.In conclusion, PEMF enhances the anticancer activity in DOX-treated MCF-7 breast cancer cells by increasing G1 cell cycle arrest and caspase-dependent apoptosis.These findings highlight the potential use of a PEMF as an adjuvant treatment for DOX-based chemotherapy against breast cancer.
No takes yet. Share an insight, caveat, or question.
Woo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: